Navigation Links
HemaQuest Pharmaceuticals, Inc. Presents Promising Clinical Results at 52nd Annual Meeting of the American Society of Hematology (ASH)
Date:12/7/2010

ORLANDO, Fla., Dec. 7, 2010 /PRNewswire/ -- HemaQuest Pharmaceuticals, Inc. (HemaQuest), a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin-associated diseases, presented encouraging results at the ASH meeting in Orlando, Florida from its first two clinical trials evaluating its lead product candidate, HQK-1001, an orally administered Small Chain Fatty Acid Derivative (SCFAD) in patients with sickle cell disease and beta thalassemia.

In the sickle cell disease clinical trial, a total of 24 patients were randomized and treated once daily at one of three dose levels (10, 20 or 30 mg/kg) of HQK-1001 or placebo for two six-week cycles of therapy with a two-week treatment break between cycles. HQK-1001 was well-tolerated with no significant drug-related adverse events. In addition, increases in fetal hemoglobin levels, the key pharmacodynamic marker, were documented in patients treated at all HQK-1001 dose levels but not in the placebo-treated patients. There was also a trend of increasing rises of fetal hemoglobin levels with increased dose up to the maximum tested dose level of 30 mg/kg. Analysis of additional pharmacodynamic markers in selected patients demonstrated induction of fetal globin as manifested by increases in fetal hemoglobin containing red blood cells (F-cells) and fetal globin mRNA in the HQK-1001 treated patients.

In the beta thalassemia clinical trial, a total of 21 patients with beta thalassemia intermedia, including Hb E thalassemia, were randomized and treated once daily with HQK-1001 at one of four dose levels (10, 20, 30 or 40 mg/kg) or placebo for eight weeks. HQK-1001 was well-tolerated with no significant drug-related adverse events. Rises in fetal hemoglobin levels were observed in HQK-1001-treated patients, with the most consistent and largest effects observed at the 20 mg/kg dose level.

HemaQuest President and CEO John Longenecker, PhD, said, "These clinical trials provide
'/>"/>

SOURCE HemaQuest Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. HemaQuest Announces Appointment of New Executive Management Team; Company Establishes Headquarters in San Diego
2. HemaQuest Pharmaceuticals Raises Additional $4M to Bring Total to $16M in Series B Financing
3. Aires Pharmaceuticals, Inc. Completes $20M Equity Financing and Signs an Option Agreement with a Major Pharmaceutical Company
4. Omthera Pharmaceuticals, Inc. to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
5. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2010 Financial Results
6. DUSA Pharmaceuticals, Inc.® to Host Third Quarter 2010 Corporate Highlights and Financial Results Conference Call
7. Pfizer Commences Tender Offer for All Outstanding Shares of King Pharmaceuticals, Inc.
8. Anadys Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
9. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
10. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
11. Star Scientific Comments on Roskamp Institutes Plans to Conduct Human Alzheimers Clinical Trials Using a Compound (RCP-006) Developed by Rock Creek Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... announced today that VPII Escrow Corp., a newly formed ... its offer of approximately $3.2 billion aggregate principal amount ... be due in 2021 and in 2023, with final ... to use the net proceeds from the offering, together ...
(Date:6/18/2013)... , June 18, 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ... focused on the development and commercialization of novel bile ... the pricing of an underwritten public offering of 1,730,000 ... price of $33.01 per share.  In addition, Intercept has ... to an additional 259,500 shares of common stock. ...
(Date:6/18/2013)... Valeant Pharmaceuticals International, Inc. (NYSE: ... announced public offering of common shares (the "Offering"). Pursuant ... shares at a price of $85.00 per share, for ... will file a final prospectus supplement to its effective ... a similar filing with the securities regulatory authorities in ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 4
... Sept. 16 Boston Scientific Corporation (NYSE: ... Drug Administration (FDA) has approved an expanded indication for ... CRT-D.  The exclusive expanded indication is effective immediately and ... the FDA for patients in all New York Heart ...
... Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) ... and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory ... do not adequately demonstrate that the potential benefits of ... a population of overweight and obese individuals to allow ...
Cached Medicine Technology:Boston Scientific Receives Exclusive Expanded Indication for Its CRT-Ds 2Boston Scientific Receives Exclusive Expanded Indication for Its CRT-Ds 3Boston Scientific Receives Exclusive Expanded Indication for Its CRT-Ds 4Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting 2Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting 3Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting 4
(Date:6/18/2013)... Philadelphia, PA, June 19, 2013 Recent studies ... coverage of bullying-related suicide among young people, led ... to assemble an expert panel to focus on ... about the complex relationship between youth involvement in ... Bullying among youth is a significant public health ...
(Date:6/18/2013)... New York, New York (PRWEB) June 19, 2013 ... dedicated to protecting the rights of victims injured by ... on behalf of an Arizona woman who alleges that ... The suit was filed on May 30th in the ... Virginia (Civil Action No. 2:13-cv-12677) in the multidistrict litigation ...
(Date:6/18/2013)... 2013 An apple a day might ... was diagnosed with breast cancer, she chose a different ... “I Gave Myself Cancer, I Can Take It Away!: ... Press), Beauregard explains how changing her physical, mental and ... have been made to feel fearful when diagnosed with ...
(Date:6/18/2013)... Looking for a way to break out of ... , IWALKAWAKE is a guide to unlocking one’s true potential ... focuses on harnessing the powerful and abundant spiritual presence that ... nine-step guide to finding one’s true purpose and potential. These ... through to reach their true potential. The awakenings deal with ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Cheap Concert Tickets ... for the tournament which gets underway in July. Soccer ... any CONCACAF ticket order. , The popularity and ... of the globe.    In fact, the hype of the game triggered ... popularity also trickled down the veins of fans from the ...
Breaking Medicine News(10 mins):Health News:Bullying and suicide among youth is a public health problem 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 3Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 4Health News:Cancer Survivor Linda Christina Beauregard Writes New Tell-All Book About Her Alternative Treatment Method 2Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 2Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 3
... HIV infection is on the rise among young men who have ... data from the Health Department. New HIV diagnoses among MSM under ... the agency reported today, from 374 in 2001 to almost 500 ... while declining by 22% among older MSM. The under-30 group now ...
... As part of an,initiative to give back ... its annual scientific meetings, the American Society for ... Wellness Community -,South Bay Cities to raise awareness ... Wellness Community will join forces with ASTRO by,participating ...
... Pa., Sept. 11 The Department of,Public Welfare ... health system whose personal information may have been ... DPW office building in Harrisburg., The burglary ... of the information on the stolen computers has ...
... 11 Crystal Research Associates, LLC,announced today that ... Tapestry Pharmaceuticals, Inc. (Nasdaq: TPPH ). The ... . Tapestry Pharmaceuticals, Inc. ("Tapestry" or "the ... that may be,effective in treating a broad spectrum ...
... Transcept,Pharmaceuticals, Inc., a specialty pharmaceutical company deriving,significant new ... Glenn A. Oclassen, President and Chief Executive Officer ... Life Sciences Conference at the Grand,Hyatt, New York, ... p.m. ET. About Transcept Pharmaceuticals Transcept ...
... CryoCor, Inc. (Nasdaq:,CRYO), a medical device company focused ... it has been invited to participate in a,Food ... held on September,20, 2007 from 8:00 am to ... committee will discuss and make recommendations regarding clinical,trial ...
Cached Medicine News:Health News:New HIV diagnoses rising in New York City among young men who have sex with men 2Health News:New HIV diagnoses rising in New York City among young men who have sex with men 3Health News:New HIV diagnoses rising in New York City among young men who have sex with men 4Health News:ASTRO, Wellness Community South Bay Cities Join to Promote Cancer Survivorship 2Health News:PA Department of Public Welfare Begins Outreach to Medical Assistance Consumers Following Burglary at State Office Building 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc. 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc. 3Health News:CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation 2
... Seat height: Bench high, 26-31". Ergonomic ... "Soft Touch" pnuematic control for easy ... Static-control casters allow easy mobility. Fixed ... Decay (from 5000 Volts to technical ...
Attachments: Clip bar for tubes 10 to 19 mm in diameter Overall Dimension Height IC: 6 (15.2) Overall Dimension Length IC: 18.5 (46.9) Overall Dimension Width IC: 4 (10.2)...
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
Medicine Products: